An alkali-soluble factor present in normal brain tissue inhibits antigen-specific lymphocyte proliferation

Journal of Neuroimmunology

Volumn 103, Issue 1, 2000, Pages 76-83

  Lindsey, J William ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Glycoprotein; Immune privilege; Immune regulation

Indexed keywords

GLYCOPROTEIN; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRAIN; CHROMATOGRAPHY, GEL; FEMALE; GANGLIOSIDES; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED ICR; NEURAMINIDASE; OVALBUMIN; SUPPRESSOR FACTORS, IMMUNOLOGIC;

EID: 0033964496     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00224-6     Document Type: Article

References (26)

1. Agrawal B., Krantz M.J., Reddish M.A., Longenecker M.B. Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nat. Med. 4:1998;43-49.
2. Akbar A.N., Salmon M. Cellular environments and apoptosis: tissue microenvironments control activated T-cell death. Immunol. Today. 18:1997;72-76.
3. Barker C.F., Billingham R.E. Immunologically privileged sites. Adv. Immunol. 25:1977;1-54.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
5. Chevrier A., Girard N., Delpech B., Gilbert D. Inhibition of active E rosette forming T lymphocytes by hyaluronic acid. Evidence of a receptor for hyaluronic acid on a lymphocyte subpopulation. Biomedicine. 36:1982;100-103.
6. Fearon D.T., Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science. 272:1996;50-54.
7. Funderburgh J.L., Mitschler R.R., Funderburgh M.L., Roth M.R., Chapes S.K., Conrad G.W. Macrophage receptors for lumican. A corneal keratan sulfate proteoglycan. Invest. Ophthalmol. Visual Sci. 38:1997;1159-1167.
8. Gilat D., Cahalon L., Hershkoviz R., Lider O. Interplay of T cells and cytokines in the context of enzymatically modified extracellular matrix. Immunol. Today. 17:1996;16-20.
9. Gordon L.B., Nolan S.C., Ksander B.R., Knopf P.M., Harling-Berg C.J. Normal cerebrospinal fluid suppresses the in vitro development of cytotoxic T cells: role of the brain microenvironment in CNS immune regulation. J. Neuroimmunol. 88:1998;77-84.
10. Gorski A., Wasik M., Nowaczyk M., Korczak-Kowalska G. Immunomodulating activity of heparin. FASEB J. 5:1991;2287-2291.
11. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., Ferguson T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1995;1189-1192.
12. Irani D.N., Lin K.I., Griffin D.E. Brain-derived gangliosides regulate the cytokine production and proliferation of activated T cells. J. Immunol. 157:1996;4333-4340.
13. Iwamori M., Nagai Y. A new chromatographic approach to the resolution of individual gangliosides. Biochim. Biophys. Acta. 528:1978;257-267.
14. Janeway C.A. Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today. 13:1992;11-16.
15. Labarca C., Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem. 102:1980;344-352.
16. Limmer A., Sacher T., Alferink J., Kretschmar M., Schoenrich G., Nichterlein T., Arnold B., Haemmerling G.J. Failure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironment. Eur. J. Immunol. 28:1998;2395-2406.
17. Manzi, A., Esko, J., 1995. Direct chemical analysis of glycoconjugates for carbohydrates. In: Ausubel, F.M., Brent, R., Kingston, R.E., et al. (Eds.), Current Protocols in Molecular Biology. Wiley, New York, 3, pp. 17.19.11-17.19.11.
18. Medawar P.B. Immunity to homologous grafted skin: III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br. J. Exp. Pathol. 29:1948;58-69.
19. Medzhitov R., Janeway C.A. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 91:1997;295-298.
20. Ruegg C.R., Chiquet-Ehrismann R., Alkan S.S. Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proc. Natl. Acad. Sci. U. S. A. 86:1989;7437-7441.
21. Streilein J.W., Ksander B.R., Taylor A.W. Immune deviation in relation to ocular immune privilege. J. Immunol. 158:1997;3557-3560.
22. Ueno K., Ando S., Yu R.K. Gangliosides of human, cat, and rabbit spinal cords and cord myelin. J. Lipid Res. 19:1978;863-871.
23. Waki H., Kon K., Tanaka Y., Ando S. Facile methods for isolation and determination of gangliosides in a small scale: age-related changes of gangliosides in mouse brain synaptic plasma membranes. Anal. Biochem. 222:1994;156-162.
24. Wilbanks G.A., Streilein J.W. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta. Eur. J. Immunol. 22:1992;1031-1036.
25. Wolfe, L.S., 1972. Methods for separation and determination of gangliosides. In: Marks, N. (Eds.), Research Methods in Neurochemistry. Plenum, New York, 1, pp. 233-248.
26. Wrenshall L.E., Cerra F.B., Carlson A., Bach F.H., Platt J.L. Regulation of murine splenocyte responses by heparan sulfate. J. Immunol. 147:1991;455-459.